Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inherited Platelet Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT06435845
What this trial is testing

Phase 2 Study on the Pharmacokinetics and Safety of RLYB212 in Pregnant Women at Higher Risk for HPA-1a Alloimmunization

Who this might be right for
Fetal and Neonatal Alloimmune Thrombocytopenia
Rallybio 1
Testing effectiveness (Phase 2)WithdrawnNCT01101412
What this trial is testing

Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies

Who this might be right for
Chronic Myeloproliferative DisordersInfectionLeukemia+6 more
M.D. Anderson Cancer Center
Not applicableUnknownNCT03880305
What this trial is testing

White Blood Cells and Platelets Indices as a Prognostic Factor in Neonatal Sepsis

Who this might be right for
Neonatal Sepsis
Assiut University 100
Not applicableWithdrawnNCT01651468
What this trial is testing

The Effect of the Nutraceutical "Hemofix" on the Coagulation System

Who this might be right for
Von Willebrand DiseaseMenorrhagia
Hadassah Medical Organization
Not applicableStudy completedNCT03110887
What this trial is testing

Monitoring Outcome in Neonatal Thrombocytopenia

Who this might be right for
Neonatal ThrombocytopeniaIntraventricular HemorrhagePlatelet Transfusion
Sanquin-LUMC J.J van Rood Center for Clinical Transfusion Research 700
Not applicableStudy completedNCT04466878
What this trial is testing

Prognostic Value of Implementing VCE on Top in Constitutional VWD-patients With GI-bleeding

Who this might be right for
Von Willebrand Diseases
University Hospital, Lille 50
Testing effectiveness (Phase 2)Ended earlyNCT03333486
What this trial is testing

Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Leukemia in RemissionAcute Lymphoblastic Leukemia+34 more
Roswell Park Cancer Institute 31
Not applicableStudy completedNCT04252534
What this trial is testing

Management of Retinitis Pigmentosa Via Electromagnetic Stimulation and Platelet Rich Plasma

Who this might be right for
Retinitis Pigmentosa
Ankara Universitesi Teknokent 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07688096
What this trial is testing

Regenerative Medicine for Joint Hypermobility and Instability

Who this might be right for
Ehlers-Danlos Syndrome Hypermobility Type (hEDS)Ehlers-Danlos Syndrome (EDS)Joint Hypermobility+8 more
Manhattan Pain Medicine, PLLC 100
Not applicableStudy completedNCT02869074
What this trial is testing

Molecular and Clinical Profile of Von Willebrand Disease in Spain

Who this might be right for
Von Willebrand Disease
Spanish Society of Thrombosis and Haemostasis 790
Testing effectiveness (Phase 2)Active Not RecruitingNCT07341919
What this trial is testing

Subtenon Autologous Platelet-Rich Plasma in Inherited and Degenerative Retinal Diseases

Who this might be right for
Extensive Macular Atrophy With Pseudodrusen (EMAP)Retinitis Pigmentosa (RP)
Rubens Camargo Siqueira 30
Not applicableStudy completedNCT00450151
What this trial is testing

Platelet Activation Markers in Pediatric Cardiac Surgery

Who this might be right for
Coronary Disease
Weill Medical College of Cornell University 10
Testing effectiveness (Phase 2)Ended earlyNCT01036802
What this trial is testing

Anticoagulation For Pulmonary Hypertension in Sickle Cell Disease

Who this might be right for
Pulmonary Hypertension
University of North Carolina, Chapel Hill 3
Testing effectiveness (Phase 2)Study completedNCT01133860
What this trial is testing

Efficacy of Eltrombopag to Improve Thrombocytopenia of MYH9-related Disease

Who this might be right for
Blood Platelet Disorders
Fondazione IRCCS Policlinico San Matteo di Pavia 12
Early research (Phase 1)Active Not RecruitingNCT03818763
What this trial is testing

Gene Therapy Trial for Platelet Derived Factor VIII Production in Hemophilia A

Who this might be right for
Hemophilia A
Medical College of Wisconsin 5
Large-scale testing (Phase 3)Looking for participantsNCT07129343
What this trial is testing

Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD)

Who this might be right for
Von Willebrand Disease (VWD)
Takeda 20
Not applicableStudy completedNCT06710262
What this trial is testing

T-TAS® wS Method Comparison

Who this might be right for
Antiplatelet TherapyHealthy DonorsVon Willebrand Disease (VWD)
Hikari Dx, Inc. 115
Testing effectiveness (Phase 2)Study completedNCT02422394
What this trial is testing

Eltrombopag for Inherited Thrombocytopenias

Who this might be right for
Inherited Platelet Disorder
Fondazione IRCCS Policlinico San Matteo di Pavia 24
Testing effectiveness (Phase 2)Study completedNCT00823524
What this trial is testing

Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Asan Medical Center 47
Testing effectiveness (Phase 2)Study completedNCT00004787
What this trial is testing

Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes

Who this might be right for
Shwachman SyndromeFanconi's AnemiaDyskeratosis Congenita+1 more
National Center for Research Resources (NCRR) 20
Next Page